leptin and propionic-acid

The objective of this study was to evaluate effects of chromium propionate (CrPr), rumen-protected lysine and methionine (RPLM), or both on metabolism, neutrophil function, and adipocyte size in lactating dairy cows (38 ± 15 d in milk). Forty-eight individually fed Holstein cows (21 primiparous, 27 multiparous) were stratified by calving date in 12 blocks and randomly assigned to 1 of 4 treatments within block. Treatments were control, CrPr (8 mg/d of Cr, KemTRACE brand chromium propionate 0.04%, Kemin Industries Inc., Des Moines, IA), RPLM (10 g/d lysine and 5 g/d methionine intestinally available, from LysiPEARL and MetiPEARL, Kemin Industries Inc.), or CrPr plus RPLM. Treatments were fed for 35 d; blood plasma samples were collected ond 21 and 35 of treatment, and blood neutrophils were isolated from 24 cows for analysis of tumor necrosis factor α (TNFα) and interleukin 1β (IL-1β) transcript abundance in the basal state and after 12h of lipopolysaccharide (LPS) activation. Tailhead subcutaneous adipose tissue samples were collected ond 35 for measurement of adipocyte size. Plasma glucose, nonesterified fatty acids, and glucagon concentrations were unaffected by treatments, whereas plasma insulin concentration was increased by RPLM. Basal TNFα transcript abundance in neutrophils was not affected by treatment, but basal IL-1β transcript abundance was decreased by RPLM and tended to be increased by CrPr. After LPS activation, CrPr increased neutrophil TNFα transcript abundance. In addition, RPLM×parity interactions were detected for both TNFα and IL-1β abundance after LPS activation, reflecting enhanced responses in primiparous cows and attenuated responses in multiparous cows supplemented with RPLM. Adipocyte size was not affected by treatment. Supplemental CrPr and RPLM had minimal effects on metabolism when fed for 35 d near peak lactation but may modulate innate immune function in lactating dairy cows.

Topics: Adipocytes; Adiponectin; Adipose Tissue; Animals; Blood Glucose; Cattle; Diet; Dietary Supplements; Fatty Acids, Nonesterified; Female; Glucagon; Insulin; Interleukin-1beta; Lactation; Leptin; Lysine; Methionine; Neutrophil Activation; Propionates; Rumen; Tumor Necrosis Factor-alpha

Short chain fatty acids (SCFAs) are the main products of indigestible carbohydrates that are fermented by microbiota in the hindgut. This study was designed to investigate the effects of oral SCFAs administration on the lipid metabolism of weaned pigs. A total of 21 barrows were randomly allocated into three groups, including control group (orally infused with 200 mL physiological saline per day), low dose SCFAs group (orally infused with 200 mL SCFAs containing acetic acid 20.04 mM, propionic acid 7.71 mM and butyric acid 4.89 mM per day), and high dose SCFAs group (orally infused with 200 mL SCFAs containing acetic acid 40.08 mM, propionic acid 15.42 mM and butyric acid 9.78 mM per day). The results showed that the average daily feed intake of SCFAs groups were lower than that of control group (P<0.05). Oral administration of SCFAs decreased the concentrations of triglyceride (TG), total cholesterol (TC), high density lipoprotein-cholesterol and insulin (P<0.05), and increased the leptin concentration in serum (P<0.05). The total fat, as well as TC and TG levels in liver, was decreased by oral SCFAs administration (P<0.05). In addition, SCFAs down-regulated the mRNA expressions of fatty acid synthase (FAS) and sterol regulatory element binding protein 1c (P<0.05), and enhanced the mRNA expression of carnitine palmitoyltransferase-1α (CPT-1α) in liver (P<0.05). SCFAs also decreased FAS, acetyl-CoA carboxylase (ACC) and peroxisome proliferator activated receptor σ mRNA expressions in longissimus dorsi (P<0.05). And in abdominal fat, SCFAs reduced FAS and ACC mRNA expressions (P<0.05), and increased CPT-1α mRNA expression (P<0.05). These results suggested that oral administration of SCFAs could attenuate fat deposition in weaned pigs via reducing lipogenesis and enhancing lipolysis of different tissues.

Topics: Acetic Acid; Acetyl-CoA Carboxylase; Adipose Tissue; Animal Feed; Animals; Butyric Acid; Carnitine O-Palmitoyltransferase; Castration; Cholesterol, HDL; Cholesterol, LDL; fas Receptor; Fatty Acid Synthase, Type I; Gene Expression Regulation; Insulin; Leptin; Lipogenesis; Lipolysis; Male; PPAR delta; Propionates; Sterol Regulatory Element Binding Protein 1; Swine; Triglycerides; Weaning

Propionate was recently shown to increase leptin synthesis in rodents. To determine if a similar effect occurs in ruminants, propionate was administered to lactating dairy cows. In experiment 1, 31 cows were given an intrajugular Na propionate bolus (1,040 micromol/kg body weight), increasing plasma propionate from 160 to 5,680 microM and plasma insulin from 6.8 to 77.8 microIU/mL. Plasma leptin concentration decreased from 2.11 ng/mL before bolus to 1.99 ng/mL after dosing (P<0.05) with no differences in leptin concentrations at 20, 50, and 100 min post-bolus (P>0.10). In experiment 2, 12 cows were used in a duplicated 6 x 6 Latin square experiment to assess the dose-response effect of ruminal propionate infusion on plasma leptin concentration. Sodium propionate was infused at rates of 0, 260, 520, 780, 1040, or 1,300 mmol/h, while total short-chain fatty acid infusion rate was held constant at 1,300 mmol/h by addition of Na acetate to the infusate. Coccygeal blood was sampled following 18 h of infusion. Increasing the rate of propionate infusion linearly increased plasma propionate concentration from 180 to 330 microM (P<0.001) and plasma insulin concentration from 6.7 to 9.1 microIU/mL (P<0.05). There was a quadratic response in plasma leptin concentration (P=0.04) with a maximum at 780 mmol/h propionate, but leptin concentrations increased by no more than 8% relative to the 0 mmol/h propionate infusion. Leptin concentrations were correlated with insulin concentrations but not with propionate concentrations in plasma. Propionate is not a physiological regulator of leptin secretion in lactating dairy cows.

Topics: Animals; Cattle; Female; Injections, Intravenous; Insulin; Leptin; Propionates